Literature DB >> 16885996

Hypertension, diuretics and breast cancer risk.

J A Largent1, A J McEligot, A Ziogas, C Reid, J Hess, N Leighton, D Peel, H Anton-Culver.   

Abstract

It is unclear whether hypertension and antihypertensive medication use are associated with breast cancer. In order to examine these associations, we conducted a case-control study among women aged 50-75 years. Breast cancer cases were ascertained via a population-based cancer registry (n=523) and controls were ascertained via random-digit-dialing (n=131). Participants completed a self-administered questionnaire which queried history of hypertension, antihypertensive medication use and risk factors. Unconditional logistic regression was used to estimate the odds ratio (OR) and 95% confidence intervals (CI), adjusted for age, body mass index (BMI), diabetes, smoking, alcohol use, menopausal status, family history of breast or ovarian cancer, age at first full-term pregnancy and education. History of treated hypertension was associated with significant increased risk of breast cancer (OR, 1.77; 95% CI, 1.04-3.03) and this association appeared only in women with BMI > or =25 kg/m(2) (OR, 2.30; 95% CI, 1.12-4.71). Diuretic use was also associated with elevated breast cancer risk (OR, 1.79; 95% CI, 1.07-3.01). The risk associated with diuretic use increased with duration of use (P for trend, <0.01). Use of other blood pressure medications was not found to be associated with breast cancer risk. These results support a positive association between treated hypertension, diuretic use and breast cancer risk among women aged 50-75 years.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16885996     DOI: 10.1038/sj.jhh.1002075

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  30 in total

1.  Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer.

Authors:  Amal Melhem-Bertrandt; Mariana Chavez-Macgregor; Xiudong Lei; Erika N Brown; Richard T Lee; Funda Meric-Bernstam; Anil K Sood; Suzanne D Conzen; Gabriel N Hortobagyi; Ana-Maria Gonzalez-Angulo
Journal:  J Clin Oncol       Date:  2011-05-31       Impact factor: 44.544

2.  A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer.

Authors:  Geoffrey C Kabat; Mimi Kim; Rowan T Chlebowski; Janu Khandekar; Marcia G Ko; Anne McTiernan; Marian L Neuhouser; Donna R Parker; James M Shikany; Marcia L Stefanick; Cynthia A Thomson; Thomas E Rohan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06-30       Impact factor: 4.254

3.  Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population.

Authors:  Lu Chen; Jessica Chubak; Denise M Boudreau; William E Barlow; Noel S Weiss; Christopher I Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-08-14       Impact factor: 4.254

4.  Negative Valence Life Events Promote Breast Cancer Development.

Authors:  Avital Fischer; Argyrios Ziogas; Hoda Anton-Culver
Journal:  Clin Breast Cancer       Date:  2017-11-01       Impact factor: 3.225

5.  Hypertension, diuretics and antihypertensives in relation to bladder cancer.

Authors:  Xuejuan Jiang; J Esteban Castelao; Jian-Min Yuan; Susan Groshen; Mariana C Stern; David V Conti; Victoria K Cortessis; Gerhard A Coetzee; Malcolm C Pike; Manuela Gago-Dominguez
Journal:  Carcinogenesis       Date:  2010-08-23       Impact factor: 4.944

6.  Breast cancer and spironolactone: an observational postmarketing study.

Authors:  Pierre Sabatier; Jacques Amar; François Montastruc; Vanessa Rousseau; Leila Chebane; Béatrice Bouhanick; Jean-Louis Montastruc
Journal:  Eur J Clin Pharmacol       Date:  2019-08-15       Impact factor: 2.953

7.  Cardiometabolic factors and breast cancer risk in U.S. black women.

Authors:  Jaclyn L F Bosco; Julie R Palmer; Deborah A Boggs; Elizabeth E Hatch; Lynn Rosenberg
Journal:  Breast Cancer Res Treat       Date:  2012-06-19       Impact factor: 4.872

8.  Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort.

Authors:  Joan A Largent; Leslie Bernstein; Pamela L Horn-Ross; Sarah F Marshall; Susan Neuhausen; Peggy Reynolds; Giske Ursin; Jason A Zell; Argyrios Ziogas; Hoda Anton-Culver
Journal:  Cancer Causes Control       Date:  2010-06-06       Impact factor: 2.506

9.  Relation of blood pressure components and categories and all-cause, stroke and coronary heart disease mortality in urban Chinese women: a population-based prospective study.

Authors:  Tsogzolmaa Dorjgochoo; Xiao Ou Shu; Xianglan Zhang; Honglan Li; Gong Yang; Lifeng Gao; Hui Cai; Yu-Tang Gao; Wei Zheng
Journal:  J Hypertens       Date:  2009-03       Impact factor: 4.844

10.  The Metabolic Syndrome Is a Risk Factor for Breast Cancer: A Systematic Review and Meta-Analysis.

Authors:  Ping Zhao; Ning Xia; Hong Zhang; Tingting Deng
Journal:  Obes Facts       Date:  2020-07-22       Impact factor: 3.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.